Key result
Reduced ejection fraction (≤40%) significantly increased the risk of long-term mortality (HR 2.61) compared to normal ejection fraction in patients with cardioembolic stroke.
Why the study?
Does lower ejection fraction predict poor short-term functional outcome and long-term mortality in patients with cardioembolic stroke?
Cohort (n=437)
No
Does lower ejection fraction predict poor short-term functional outcome and long-term mortality in patients with cardioembolic stroke?
Effect estimate: HR 2.61 (95% CI 1.64-4.17)
Lower ejection fraction is strongly associated with increased long-term mortality in patients with cardioembolic stroke, highlighting the prognostic value of echocardiographic evaluation in this population.
Supports EF assessment for mortality risk stratification in cardioembolic stroke; leaves open whether interventions improve outcomes.
BACKGROUND: The relationship between whole spectrum of Ejection fraction (EF) and cardioembolic stroke (CES) outcome has not been fully described yet. Notably, it remains unclear whether borderline EF (41∼49%) is related with poor outcome after CES. We sought to evaluate whether lower ejection fraction and borderline EF could predict the outcome in patients with CES. METHOD AND RESULTS: We evaluated the relationship between EF and functional outcome in 437 consecutive patients with CES. EF was introduced as continuous and categorical (EF≤40%, EF 41∼49%, EF≥50%) variable. Patients with CES and the subgroup with AF were evaluated separately. Poor short-term outcome (modified Rankin Score≥3at discharge or death within 90 days after stroke onset) and long-term mortality were evaluated. A total of 165 patients (37.8%) had poor short-term outcomes. EF tends to be lower in patients with poor short-term outcome (56.8±11.0 vs. 54.8±12.0, p-value 0.086). Overall cumulative death was136 (31.1%) in all CES patients and 106 (31.7%) in the AF subgroup. In a multivariable model adjusted for possible covariates, the hazard ratio for mortality significantly decreased by 3% for every 1% increase in ejection fraction in CES patients and 2% for every 1% increase in the AF subgroup. Reduced EF (EF≤40%) showed higher mortality (HR 2.61), and those with borderline EF (41∼49%) had a tendency of higher mortality (HR 1.65, p-value 0.067)compared with those with normal EF. CONCLUSION: We found a strong association between lower EF and CES outcome. Echocardiographic evaluation helps to better determine the prognosis in CES patients, even in subgroup of patients with AF.
No takes yet. Share an insight, caveat, or question.
Byun et al. (2014) conducted a cohort in Cardioembolic stroke (n=437). Reduced ejection fraction (≤40%) vs. Normal ejection fraction (≥50%) was evaluated on Long-term mortality (HR 2.61, 95% CI 1.64-4.17). Reduced ejection fraction (≤40%) significantly increased the risk of long-term mortality (HR 2.61) compared to normal ejection fraction in patients with cardioembolic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: